Related Experiment Video
Updated: Apr 25, 2026

Droplet-based Cytotoxicity Assay to Assess Chimeric Antigen Receptor T cells at the Single-cell Level
Published on: March 14, 2025
Modeling chimeric antigen receptor response at the single-cell level with conditional optimal transport
Alice Driessen1, Jannis Born2, Rocio Castellanos Rueda3
1IBM Research Europe, Zurich, Switzerland; Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
Abstract:
Chimeric antigen receptor (CAR) T cell therapy is a promising cancer immunotherapy; however, several challenges hamper its clinical efficacy. Although new computational models are attempting to explore the vast combinatorial design space of CAR components and suggest novel designs, challenges remain in capturing cellular heterogeneity as well as generalizing to unseen CAR variants. Here, we introduce an optimal transport (OT)-based framework designed to predict responses to CAR expression at the single-cell level, including variants that have not been experimentally tested. Our model accurately captures gene expression changes across diverse CAR variants, outperforming the baseline for in-distribution CARs while reflecting biological characteristics. By embedding CARs using protein language models, we extend our framework to a conditional OT-based model that successfully generalizes our predictions to out-of-distribution CAR designs. Our findings highlight the utility of OT-based modeling in elucidating CAR design-function relationships, enabling the rational design of novel CARs with therapeutic potential. A record of this paper's transparent peer review process is included in the supplemental information.
Insights
This study introduces an optimal transport framework to predict responses to chimeric antigen receptor (CAR) T cell therapy at the single-cell level. The model accurately predicts gene expression changes and generalizes to novel CAR designs for improved cancer immunotherapy.
Area of Science:
- Immunology
- Computational Biology
- Bioinformatics
Background:
- Chimeric antigen receptor (CAR) T cell therapy shows promise for cancer treatment but faces challenges in clinical efficacy.
- Current computational models struggle to capture cellular heterogeneity and generalize to new CAR variants.
Purpose of the Study:
- To develop a computational framework for predicting CAR T cell therapy responses at the single-cell level.
- To enable the rational design of novel CARs by elucidating CAR design-function relationships.
Main Methods:
- An optimal transport (OT)-based framework was developed to predict CAR expression responses.
- Protein language models were used to embed CARs, extending the framework to a conditional OT-based model.
- The model was evaluated for its ability to capture gene expression changes and generalize to unseen CAR variants.
Main Results:
- The OT-based model accurately captures gene expression changes across diverse CAR variants.
- The model outperforms baseline methods for in-distribution CARs and reflects biological characteristics.
- The conditional OT-based model successfully generalizes predictions to out-of-distribution CAR designs.
Conclusions:
- Optimal transport-based modeling is valuable for understanding CAR design-function relationships.
- This framework facilitates the rational design of novel CARs with therapeutic potential.
- The developed model enhances the prediction of CAR T cell therapy responses.
More Related Videos
09:12Efficient Retroviral Transduction and Competitive Homing for Investigating GPCR-Mediated T-Cell Localization in Diverse Tissue Microenvironments
Published on: March 28, 2025
08:26Isolation, Cultivation, and Transient Transfection of Primary Human T Cells to Generate Chimeric Antigen Receptor (CAR) T Cells
Published on: March 27, 2026